Horizon Therapeutics Public Ltd Co

BNP PARIBAS FINANCIAL MARKETS

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

98,385

Value ($000)

11,382

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	11,382	0.0%	98,385	9/30/2023
2023 Q2	8/9/2023	15,811	0.0%	153,731	6/30/2023
2023 Q1	5/12/2023	33,067	0.1%	302,976	3/31/2023
2022 Q4	2/14/2023	18,533	0.0%	162,852	12/31/2022
2022 Q3	11/16/2022	11,435	0.0%	184,764	9/30/2022
2022 Q2	8/12/2022	11,666	0.0%	146,259	6/30/2022
2022 Q1	5/18/2022	17,254	0.0%	163,992	3/31/2022
2021 Q4	2/9/2022	22,012	0.1%	204,267	12/31/2021
2021 Q3	11/16/2021	4,539	0.0%	41,436	9/30/2021
2021 Q2	8/10/2021	5,025	0.0%	53,660	6/30/2021
2021 Q1	5/7/2021	63,878	0.1%	694,025	3/31/2021
2020 Q4	2/10/2021	4,597	0.0%	62,841	12/31/2020
2020 Q3	10/30/2020	390	0.0%	5,022	9/30/2020
2020 Q2	8/6/2020	6,432	0.0%	115,724	6/30/2020
2020 Q1	5/13/2020	4,496	0.0%	151,804	3/31/2020
2019 Q4	2/12/2020	1,799	0.0%	49,695	12/31/2019